Drugs / Ad5-CB-CFTR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004779 | Jan 1993 → ? | cystic fibrosis | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5-CB-CFTR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004779 ↗ |
| Action | Restore | “ion transport abnormalities in CF airway cells can be corrected” NCT00004779 ↗ |
| Route | Intranasal | “Ad5-CB-CFTR is administered to 1 nasal cavity” NCT00004779 ↗ |